References
- Dubecz A, Solymosi N, Stadlhuber RJ, Schweigert M, Stein HJ, Peters JH. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century?-a SEER database analysis. J Gastrointest Surg 2013; Epub 2013/11/16. 10.1007/s11605-013-2345-8
- Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-6. 10.1093/jnci/dji02415657344
- Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol 2008; 23: 1662-5. 10.1111/j.1440-1746.2008.05572.x
- Blaser MJ, Saito D. Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan. Eur J Gastroenterol Hepatol 2002; 14: 107-13.10.1097/00042737-200202000-0000311981333
- Yamashita K, Sakuramoto S, Nemoto M, Shibata T, Mieno H, Katada N, et al. Trend in gastric cancer: 35 years of surgical experience in Japan. World J Gastroenterol 2011; 17: 3390-7. 10.3748/wjg.v17.i29.339021876631
- Mariette C, Castel B, Toursel H, Fabre S, Balon JM, Triboulet JP. Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg 2002; 89: 1156-63. 10.1046/j.1365-2168.2002.02185.x12190682
- Haverkamp L, Ruurda JP, van Leeuwen MS, Siersema PD, van Hillegersberg R. Systematic review of the surgical strategies of adenocarcinomas of the gastroesophageal junction. Surg Oncol 2014; 23: 222-8. 10.1016/j.suronc.2014.10.00425466852
- Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-9. 10.1046/j.1365-2168.1998.00940.x9823902
- Kauppila JH, Lagergren J. The surgical management of esophago-gastric junctional cancer. Surg Oncol 2016; 25: 394-400. 10.1016/j.suronc.2016.09.00427916171
- Kulig P, Sierzega M, Pach R, Kolodziejczyk P, Kulig J, Group PGCS. Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location. Eur J Surg Oncol 2016; 42: 1215-21. 10.1016/j.ejso.2016.04.061
- Mine S, Sano T, Hiki N, Yamada K, Kosuga T, Nunobe S, et al. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg 2013; 100: 1050-4. 10.1002/bjs.917023754647
- Wei MT, Zhang YC, Deng XB, Yang TH, He YZ, Wang ZQ. Transthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysis. World J Gastroenterol 2014; 20: 10183-92. 10.3748/wjg.v20.i29.1018325110447
- Blank S, Schmidt T, Heger P, Strowitzki MJ, Sisic L, Heger U, et al. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach? Gastric Cancer 2017. Epub 2017/07/06. 10.1007/s10120-017-0746-1
- Uzunoglu FG, Reeh M, Kutup A, Izbicki JR. Surgery of esophageal cancer. Langenbecks Arch Surg 2013; 398: 189-93. 10.1007/s00423-013-1052-y23354360
- Al-Haddad S, Chang AC, De Hertogh G, Grin A, Langer R, Sagaert X, et al. Adenocarcinoma at the gastroesophageal junction. Ann N Y Acad Sci 2014; 1325: 211-25. 10.1111/nyas.1253525266027
- Di Leo A, Zanoni A. Siewert III adenocarcinoma: treatment update. Updates Surg 2017. Epub 2017/03/16. 10.1007/s13304-017-0429-9
- Yamashita H, Seto Y, Sano T, Makuuchi H, Ando N, Sasako M. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer 2017; 20(Suppl 1): 69-83. 10.1007/s10120-016-0663-827796514
- Kleinberg L, Brock M, Gibson M. Management of locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: Finally a consensus. Curr Treat Options Oncol 2015; 16: 35. 10.1007/s11864-015-0352-626112428
- Cohen DJ, Leichman L. Controversies in the treatment of local and locally advanced gastric and esophageal cancers. J Clin Oncol 2015; 33: 1754-9. 10.1200/jco.2014.59.776525918302
- Roder JD, Bottcher K, Busch R, Wittekind C, Hermanek P, Siewert JR. Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer 1998; 82: 621-31.10.1002/(SICI)1097-0142(19980215)82:4<;621::AID-CNCR2>3.0.CO;2-O
- Doyle DJ, Garmon E. American Society of Anesthesiologists Classification (ASA Class). StatPearls. Treasure Island (FL): StatPearls PublishingStatPearls Publishing LLC.; 2017.
- Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998; 1: 10-24. 10.1007/s101209800016
- Goto H, Tokunaga M, Sugisawa N, Tanizawa Y, Bando E, Kawamura T, et al. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction. Gastric Cancer 2013; 16: 590-5. 10.1007/s10120-012-0214-x23179369
- Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt to a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
- TNM classification of malignant tumours. Eighth edition. Brierley J, Gospodarowicz MK, Wittekind C, editors. Chichester, West Sussex: John Wiley & Sons, Inc; 2017.
- Wittekind C. [Patology of gastric carcinoma: typing, grading and staging]. [German]. Chir Gastroenterol 1999; 15: 216-22. 10.1159/000012560.
- Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13. org/10.1097/01.sla.0000133083.54934.ae.
- Fox MP, van Berkel V. Management of gastroesophageal junction tumors. Surg Clin North Am 2012; 92: 1199-212. 10.1016/j.suc.2012.07.01123026278
- Mullen JT, Kwak EL, Hong TS. What’s the best way to treat GE junction tumors? Approach like gastric cancer. Ann Surg Oncol 2016; 23: 3780-5. 10.1245/s10434-016-5426-627459983
- Rizk N. Gastroesophageal junction tumors. Ann Surg Oncol 2016; 23: 3798-800. 10.1245/s10434-016-5427-527491783
- Giacopuzzi S, Bencivenga M, Weindelmayer J, Verlato G, de Manzoni G. Western strategy for EGJ carcinoma. Gastric Cancer 2017; 20(Suppl 1): 60-8. 10.1007/s10120-016-0685-228039533
- Duan F, Cui S, Song C, Zhao X, Dai L, Shen Y. Esophageal squamous cell carcinoma and gastric cardia adenocarcinoma shared susceptibility locus in C20orf54: Evidence from published studies. Sci Rep 2015; 5: 11961. 10.1038/srep1196126154995
- Hosoda K, Yamashita K, Moriya H, Mieno H, Watanabe M. Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: a retrospective cohort study with long-term follow-up. World J Gastroenterol 2017; 23: 2723-30. 10.3748/wjg.v23.i15.272328487609
- Lee IS, Ahn JY, Yook JH, Kim BS. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma. World J Surg Oncol 2017; 15: 28. 10.1186/s12957-016-1088-x28100248
- Lochowski M, Lochowska B, Kozak J. Transthoracic versus transhiatal esophagectomy - influence on patient survival. Prz Gastroenterol 2017; 12: 118-21. 10.5114/pg.2016.6460928702100
- Fontana MG, La Pinta M, Moneghini D, Villanacci V, Donato F, Rindi G, et al. Prognostic value of Goseki histological classification in adenocarcinoma of the cardia. Br J Cancer 2003; 88: 401-5. 10.1038/sj.bjc.660066312569383
- Kurokawa Y, Sasako M, Sano T, Yoshikawa T, Iwasaki Y, Nashimoto A, et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br JSurg 2015; 102: 341-8. 10.1002/bjs.976425605628
- Mine S, Watanabe M. A commentary on “Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia”. Transl Gastroenterol Hepatol 2016; 1: 12. 10.21037/tgh.2016.03.08
- Kim KT, Jeong O, Jung MR, Ryu SY, Park YK. Outcomes of abdominal total gastrectomy for type II and III gastroesophageal junction tumors: Single center’s experience in Korea. J Gastric Cancer 2012; 12: 36-42. 10.5230/jgc.2012.12.1.3622500262